Psyence Group Inc.
Psyence Group Inc. is a science-led global psychedelic platform, led by experts in neurology, neuroscience and drug development. Psyence has built and operates one of the first federally licensed commercial psilocybin cultivation and production facilities. Psyence is pioneering the use of natural psilocybin for the long-term treatment of psychological trauma and its mental health consequences.
Psyence Group Inc. (PSYG)
Le 26 janvier/January 2021
The common shares of Psyence Group Inc. previously listed as Cardinal Capital Partners Inc. have been approved for listing on the CSE.
Listing and disclosure documents will be available at www.thecse.com on the trading date.